Johnson & Johnson tops expectations in Q2 as medicines sales support outlook
The company reported $25.31 billion in quarterly sales and lifted its full-year forecast to about $101.1 billion at the midpoint, citing strength in its medicines business.
Business headlines from the Apex backend, organized by sectors and major public companies for faster market scanning.
The company reported $25.31 billion in quarterly sales and lifted its full-year forecast to about $101.1 billion at the midpoint, citing strength in its medicines business.
THE APEX TIMES
In comments on CNBC, Warren Buffett said he initiated Berkshire Hathaway’s Alphabet position, while also stressing that he considers Alphabet a lower-priority stake compared with several other Berkshire investments.
In results released for the second quarter, Morgan Stanley said multiple measures reached record highs, finishing a stretch of “big bank” earnings that investors have been watching for signs of sustained dealmaking and market activity.
Investors pushed BlackRock’s stock higher after the asset manager reported results that topped Wall Street expectations, alongside a jump in total assets under management to $15.3 trillion.
Ahead of the opening bell on Wednesday, July 15, analysts are looking for Johnson & Johnson to post quarterly earnings of $2.85 per share, compared with $2.77 per share a year earlier. A Yahoo Finance piece also framed the event as an opportunity for income-seeking investors, though it did not provide details in the information available here.
Markets were poised to extend recent gains as investors weighed another wave of quarterly results, with earnings season prompting a narrow focus on specific corporate updates.
A full-year outlook lift tied to stronger-than-expected second-quarter results was not enough to calm concerns around weakness in Stelara sales, even as oncology performance helped offset the decline.
The adjustment reflects expectations of intensifying artificial intelligence spending, even as the analyst keeps a constructive view on the software and cloud giant.
A fresh analyst note points to NVIDIA’s effort to build “full-stack” artificial-intelligence infrastructure, spanning networking and central processing units, alongside its GPU dominance.